Orphan designation: 6,8-bis(benzylthio)octanoic acid, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-d6788f ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Acid Treatment ◽

Octanoic Acid ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: 6,8-bis(benzylthio)octanoic acid, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-d6cc8d ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Acid Treatment ◽

Octanoic Acid ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: recombinant human interleukin-3 truncated diphtheria toxin fusion protein, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-d91fd7 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Fusion Protein ◽

Myeloid Leukaemia ◽

Diphtheria Toxin ◽

Orphan Designation ◽

Interleukin 3 ◽

Protein Treatment ◽

Acute Myeloid

Download Full-text

Orphan designation: Ivosidenib, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-2370f8b ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: Ulocuplumab, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-17404b5 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: CD33-directed antibody-drug conjugate consisting of an antibody conjugated to a DNA cross-linking pyrrolobenzodiazepine dimer drug (vadastuximab talirine), Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-1740561 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cross Linking ◽

Antibody Drug Conjugate ◽

Orphan Designation ◽

Drug Conjugate ◽

Pyrrolobenzodiazepine Dimer ◽

Acute Myeloid ◽

Antibody Drug

Download Full-text

Orphan designation: Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu and Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-ff5e18 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: Venetoclax, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-ff52cd ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: azacitidine, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-bc6b4c ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

MGI Pharma's decitabine [Dacogen] for injection has received orphan designation from the EMEA for acute myeloid leukaemia

Inpharma Weekly ◽

10.2165/00128413-200615500-00062 ◽

2006 ◽

Vol &NA; (1550) ◽

pp. 22

Author(s):

&NA;

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text

Orphan designation: (S)-5-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile, Treatment of acute myeloid leukaemia

Case Medical Research ◽

10.31525/cmr-19c815a ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Orphan Designation ◽

Acute Myeloid

Download Full-text